{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:40:22Z","timestamp":1793234422765,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752177"],"award-info":[{"award-number":["2024M752177"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005024","name":"Beijing Postdoctoral Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7254345"],"award-info":[{"award-number":["7254345"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neuropharm.2026.110845","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:18:08Z","timestamp":1768925888000},"page":"110845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The novel PSD-95 inhibitor BXOS110 provides neuroprotection in acute ischemic stroke"],"prefix":"10.1016","volume":"288","author":[{"given":"Huan-Yu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Rong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1934-8643","authenticated-orcid":false,"given":"Tian-Jie","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-2476","authenticated-orcid":false,"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge-Hong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7500-5422","authenticated-orcid":false,"given":"Hua-Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5594","key":"10.1016\/j.neuropharm.2026.110845_bib1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1126\/science.1072873","article-title":"Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions","volume":"298","author":"Aarts","year":"2002","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.neuropharm.2026.110845_bib2","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.286.21.2673","article-title":"Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial","volume":"286","author":"Albers","year":"2001","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.neuropharm.2026.110845_bib3","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1021\/jm800836w","article-title":"Modified peptides as potent inhibitors of the postsynaptic density-95\/N-methyl-D-aspartate receptor interaction","volume":"51","author":"Bach","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110845_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2019.02.035","article-title":"Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor","volume":"150","author":"Bach","year":"2019","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110845_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/aps.2018.5","article-title":"Discovery and development of NA-1 for the treatment of acute ischemic stroke","volume":"39","author":"Ballarin","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110845_bib6","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1161\/STROKEAHA.111.618801","article-title":"Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor","volume":"42","author":"Bratane","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2026.110845_bib7","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.88919","article-title":"Functional ultrasound imaging of stroke in awake rats","volume":"12","author":"Brunner","year":"2023","journal-title":"eLife"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2026.110845_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jchromb.2006.12.053","article-title":"Quantitative analysis of Tenecteplase in rat plasma samples using LC-MS\/MS as an alternative for ELISA","volume":"852","author":"Buscher","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.neuropharm.2026.110845_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.579953","article-title":"Excitotoxicity: still hammering the Ischemic Brain in 2020","volume":"14","author":"Choi","year":"2020","journal-title":"Front. Neurosci."},{"issue":"10478","key":"10.1016\/j.neuropharm.2026.110845_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(25)00193-X","article-title":"Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study","volume":"405","author":"Christenson","year":"2025","journal-title":"Lancet"},{"issue":"39","key":"10.1016\/j.neuropharm.2026.110845_bib11","doi-asserted-by":"crossref","first-page":"27467","DOI":"10.1074\/jbc.274.39.27467","article-title":"PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain","volume":"274","author":"Christopherson","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"10440","key":"10.1016\/j.neuropharm.2026.110845_bib12","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global Burden of Disease Study 2021","volume":"403","author":"Collaborators","year":"2024","journal-title":"Lancet"},{"issue":"7388","key":"10.1016\/j.neuropharm.2026.110845_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature10841","article-title":"Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain","volume":"483","author":"Cook","year":"2012","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110845_bib14","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/01.STR.26.10.1852","article-title":"Unified Neurological Stroke Scale is valid in ischemic and hemorrhagic stroke","volume":"26","author":"Edwards","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2026.110845_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuroimage.2017.01.071","article-title":"3D functional ultrasound imaging of the cerebral visual system in rodents","volume":"149","author":"Gesnik","year":"2017","journal-title":"Neuroimage"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110845_bib16","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1474-4422(12)70225-9","article-title":"Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"11","author":"Hill","year":"2012","journal-title":"Lancet Neurol."},{"issue":"10227","key":"10.1016\/j.neuropharm.2026.110845_bib17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","article-title":"Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial","volume":"395","author":"Hill","year":"2020","journal-title":"Lancet"},{"issue":"10478","key":"10.1016\/j.neuropharm.2026.110845_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0140-6736(25)00194-1","article-title":"Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial","volume":"405","author":"Hill","year":"2025","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110845_bib19","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.STR.22.10.1270","article-title":"MK-801 does not protect against hypoxic-ischemic brain injury in piglets","volume":"22","author":"LeBlanc","year":"1991","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110845_bib20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1177\/0271678X17700913","article-title":"Imaging the physiological evolution of the ischemic penumbra in acute ischemic stroke","volume":"38","author":"Leigh","year":"2018","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110845_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/bc.bc_36_18","article-title":"Treatment for ischemic stroke: from thrombolysis to thrombectomy and remaining challenges","volume":"5","author":"Leng","year":"2019","journal-title":"Brain Circ"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110845_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1871527320666210212141232","article-title":"Role of calcium homeostasis in ischemic stroke: a review","volume":"21","author":"Ludhiadch","year":"2022","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"issue":"588","key":"10.1016\/j.neuropharm.2026.110845_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb1498","article-title":"Plasmin-resistant PSD-95 inhibitors resolve effect-modifying drug-drug interactions between alteplase and nerinetide in acute stroke","volume":"13","author":"Mayor-Nunez","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110845_bib24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/01.STR.0000227243.96808.53","article-title":"Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements","volume":"37","author":"Murphy","year":"2006","journal-title":"Stroke"},{"issue":"5421","key":"10.1016\/j.neuropharm.2026.110845_bib25","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1126\/science.284.5421.1845","article-title":"Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein","volume":"284","author":"Sattler","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110845_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113125","article-title":"Glutamate excitotoxicity: potential therapeutic target for ischemic stroke","volume":"151","author":"Shen","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.110845_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107574","article-title":"Reperfusion injury in acute ischemic stroke: tackling the irony of revascularization","volume":"225","author":"Soldozy","year":"2023","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"5296","key":"10.1016\/j.neuropharm.2026.110845_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.275.5296.73","article-title":"Recognition of unique carboxyl-terminal motifs by distinct PDZ domains","volume":"275","author":"Songyang","year":"1997","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.neuropharm.2026.110845_bib29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2165\/00003088-200241150-00001","article-title":"Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction","volume":"41","author":"Tanswell","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110845_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.1455","article-title":"Estimated Burden of Stroke in China in 2020","volume":"6","author":"Tu","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110845_bib31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1474-4422(24)00515-5","article-title":"Safety and efficacy of nerinetide in patients with acute ischaemic stroke enrolled in the early window: a post-hoc meta-analysis of individual patient data from three randomised trials","volume":"24","author":"Tymianski","year":"2025","journal-title":"Lancet Neurol."},{"issue":"13","key":"10.1016\/j.neuropharm.2026.110845_bib32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/WNR.0000000000000849","article-title":"Perturbing NR2B-PSD-95 interaction relieves neuropathic pain by inactivating CaMKII-CREB signaling","volume":"28","author":"Xu","year":"2017","journal-title":"Neuroreport"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110845_bib33","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/STROKEAHA.124.047483","article-title":"Decreased quantitative cerebral blood volume is associated with poor outcomes in large core patients","volume":"55","author":"Yedavalli","year":"2024","journal-title":"Stroke"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:39:21Z","timestamp":1777426761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"alternative-id":["S0028390826000183"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110845","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel PSD-95 inhibitor BXOS110 provides neuroprotection in acute ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110845"}}